Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
27
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1043
0.480
 Why?
Leukemia, Myeloid, Acute
4
2010
208
0.370
 Why?
Osteosarcoma
2
2016
44
0.310
 Why?
Hematology
1
2009
23
0.300
 Why?
von Willebrand Diseases
1
2009
24
0.300
 Why?
Sclerotherapy
2
2020
47
0.300
 Why?
Antineoplastic Agents
5
2016
1232
0.270
 Why?
Vascular Malformations
2
2020
105
0.270
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.260
 Why?
Hemophilia B
1
2007
5
0.260
 Why?
Hemostasis, Surgical
1
2007
11
0.260
 Why?
Blood Coagulation Factors
1
2007
17
0.260
 Why?
Enoxaparin
1
2007
32
0.260
 Why?
Blood Loss, Surgical
1
2007
66
0.250
 Why?
Child, Preschool
13
2020
4162
0.250
 Why?
Venous Thrombosis
1
2007
91
0.240
 Why?
Cisplatin
3
2016
282
0.240
 Why?
Cyclosporine
1
2005
64
0.230
 Why?
Blood Coagulation Disorders
2
2020
41
0.220
 Why?
Hemostasis
2
2020
55
0.220
 Why?
Leukemia
1
2005
67
0.220
 Why?
Cladribine
1
2004
3
0.220
 Why?
Bone Regeneration
2
2016
70
0.210
 Why?
Histiocytosis, Langerhans-Cell
1
2004
34
0.210
 Why?
Retinoblastoma
1
2003
15
0.200
 Why?
Retinal Neoplasms
1
2003
13
0.200
 Why?
Infant
11
2018
3805
0.200
 Why?
Neoplasms
3
2012
1334
0.190
 Why?
Neoplasms, Second Primary
1
2003
75
0.190
 Why?
Child
14
2020
7379
0.180
 Why?
Bone Neoplasms
1
2003
188
0.170
 Why?
Thrombelastography
1
2020
27
0.170
 Why?
Adolescent
11
2020
6907
0.160
 Why?
Bleomycin
1
2018
38
0.140
 Why?
Down Syndrome
3
2008
95
0.130
 Why?
Antibiotics, Antineoplastic
1
2018
83
0.130
 Why?
Osteogenesis, Distraction
2
2016
78
0.130
 Why?
Piperazines
2
2016
125
0.120
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.120
 Why?
Leukemia, Myeloid
2
2008
40
0.120
 Why?
Humans
21
2020
53230
0.120
 Why?
Disease-Free Survival
5
2010
466
0.120
 Why?
Imidazoles
1
2016
114
0.110
 Why?
Remission Induction
4
2011
221
0.110
 Why?
Male
13
2020
27435
0.110
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
92
0.110
 Why?
Leukocyte Count
2
2005
71
0.100
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
38
0.100
 Why?
Survival Analysis
4
2010
659
0.100
 Why?
Doxorubicin
2
2005
247
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
9
0.090
 Why?
Neutropenia
1
2012
113
0.090
 Why?
Sarcoma, Myeloid
1
2011
20
0.090
 Why?
Heart Neoplasms
1
2011
31
0.090
 Why?
Treatment Outcome
7
2018
5595
0.080
 Why?
Core Binding Factors
1
2010
3
0.080
 Why?
Proto-Oncogene Proteins c-kit
1
2010
34
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Listeriosis
1
2009
6
0.080
 Why?
Female
10
2020
28782
0.080
 Why?
Anemia, Aplastic
1
2009
10
0.070
 Why?
Platelet Transfusion
1
2009
33
0.070
 Why?
Histocompatibility Testing
1
2008
14
0.070
 Why?
Acute Lung Injury
1
2009
30
0.070
 Why?
HLA Antigens
1
2008
55
0.070
 Why?
Abdominal Pain
1
2009
84
0.070
 Why?
Bone Marrow Transplantation
1
2008
110
0.070
 Why?
Young Adult
5
2020
4511
0.070
 Why?
Hospitals, Pediatric
1
2009
243
0.070
 Why?
Retrospective Studies
6
2018
6819
0.070
 Why?
Adult
7
2020
14534
0.070
 Why?
Infusions, Intravenous
2
2004
211
0.060
 Why?
Cardiomyopathies
1
2008
120
0.060
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
77
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
868
0.060
 Why?
Tamoxifen
1
2005
60
0.060
 Why?
Heart
1
2008
350
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.050
 Why?
Proto-Oncogene Proteins
1
2004
150
0.050
 Why?
Immunosuppressive Agents
1
2005
253
0.050
 Why?
Humerus
1
2003
17
0.050
 Why?
Arkansas
1
2009
2068
0.050
 Why?
Mutation
2
2010
1337
0.050
 Why?
Tibia
1
2003
118
0.050
 Why?
Methotrexate
1
2003
78
0.050
 Why?
Survivors
1
2003
120
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
19
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
392
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1367
0.040
 Why?
Blood Coagulation Tests
1
2020
18
0.040
 Why?
Blood Flow Velocity
1
2020
99
0.040
 Why?
Blood Coagulation
1
2020
65
0.040
 Why?
Follow-Up Studies
2
2018
2318
0.040
 Why?
Prognosis
3
2012
2118
0.040
 Why?
Mice, Inbred C57BL
2
2016
1925
0.040
 Why?
Gene Expression Profiling
1
2004
1112
0.040
 Why?
Hemorrhage
1
2020
226
0.040
 Why?
Daunorubicin
2
2008
15
0.030
 Why?
Cytarabine
2
2006
44
0.030
 Why?
Mice, Nude
1
2016
232
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
228
0.030
 Why?
Random Allocation
1
2016
284
0.030
 Why?
Acute Disease
2
2008
393
0.030
 Why?
Cluster Analysis
2
2005
237
0.030
 Why?
Prospective Studies
2
2012
2411
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
412
0.030
 Why?
Interleukin-3
1
2012
12
0.020
 Why?
Calcitonin Gene-Related Peptide
1
2012
23
0.020
 Why?
Protein Precursors
1
2012
42
0.020
 Why?
Calcitonin
1
2012
30
0.020
 Why?
Sensitivity and Specificity
2
2006
867
0.020
 Why?
Interleukin-8
1
2012
85
0.020
 Why?
Interleukin-10
1
2012
81
0.020
 Why?
ROC Curve
1
2012
246
0.020
 Why?
Fatal Outcome
1
2011
193
0.020
 Why?
Mice, Knockout
1
2013
910
0.020
 Why?
Interleukin-6
1
2012
272
0.020
 Why?
Intensive Care Units
1
2012
243
0.020
 Why?
Animals
2
2016
13526
0.020
 Why?
Pilot Projects
1
2012
726
0.020
 Why?
Exons
1
2010
100
0.020
 Why?
Time Factors
2
2008
2991
0.020
 Why?
Opportunistic Infections
1
2009
56
0.020
 Why?
Echocardiography
1
2011
409
0.020
 Why?
Translocation, Genetic
1
2010
266
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Hospitalization
1
2012
749
0.020
 Why?
Proportional Hazards Models
1
2008
445
0.020
 Why?
Recurrence
1
2008
694
0.020
 Why?
Genetic Predisposition to Disease
1
2010
533
0.020
 Why?
Prevalence
1
2010
1034
0.020
 Why?
Immunophenotyping
1
2006
118
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1180
0.020
 Why?
Luciferases
1
2005
50
0.010
 Why?
Nucleic Acid Hybridization
1
2005
53
0.010
 Why?
Diagnosis, Differential
1
2009
1038
0.010
 Why?
Cell Membrane
1
2006
233
0.010
 Why?
DNA Primers
1
2005
202
0.010
 Why?
Middle Aged
1
2020
13419
0.010
 Why?
Transfection
1
2005
359
0.010
 Why?
Tumor Cells, Cultured
1
2005
441
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
20
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1583
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
579
0.010
 Why?
Benzamides
1
2004
52
0.010
 Why?
Risk Assessment
1
2008
1368
0.010
 Why?
Risk Factors
1
2012
4017
0.010
 Why?
Mice
1
2013
5982
0.010
 Why?
Pyrimidines
1
2004
205
0.010
 Why?
Nuclear Proteins
1
2004
250
0.010
 Why?
DNA Helicases
1
2004
148
0.010
 Why?
DNA-Binding Proteins
1
2004
423
0.010
 Why?
Predictive Value of Tests
1
2004
934
0.010
 Why?
Drug Administration Schedule
1
2002
370
0.010
 Why?
Linear Models
1
2002
287
0.010
 Why?
Transcription Factors
1
2004
571
0.010
 Why?
Analysis of Variance
1
2002
547
0.010
 Why?
Neutrophils
1
2002
153
0.010
 Why?
Patient Selection
1
2002
273
0.010
 Why?
Infant, Newborn
1
2006
2913
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department